| Gene Therapy with Lipid Nanoparticles for Fabry Disease: Leveraging E-Selectin for Targeted Delivery to Endothelial Cells J Rodríguez-Castejón, JA Plantinga, M Beraza-Millor, MÁ Solinís, ... Journal of Drug Delivery Science and Technology, 105954, 2024 | | 2024 |
| Optimizing antibiotic therapy for stenotrophomonas maltophilia infections in critically Ill patients: A pharmacokinetic/pharmacodynamic approach H Barrasa González, MÁ Morán Rodríguez, L Fernández Ciriza, ... MDPI, 2024 | | 2024 |
| Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach H Barrasa, MA Morán, L Fernández-Ciriza, A Isla, MÁ Solinís, ... Antibiotics 13 (6), 553, 2024 | | 2024 |
| Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital A Rodríguez-Gascón, Y Lloréns-Villar, MÁ Solinís, H Barrasa, ... European Journal of Clinical Microbiology & Infectious Diseases 43 (5), 885-893, 2024 | 1 | 2024 |
| Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review J Rodríguez-Castejón, M Beraza-Millor, MÁ Solinís, A Rodríguez-Gascón, ... Drug Delivery and Translational Research, 1-14, 2024 | | 2024 |
| Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: A prospective, open-label, non-inferiority, randomised … M Ubals, P Nadal-Baron, M Arando, Á Rivero, A Mendoza, VD Jorro, ... The Lancet Infectious Diseases 24 (4), 404-416, 2024 | 2 | 2024 |
| Streptococcus pneumoniae eta Haemophilus influenzae bakterio-espezieek eragindako infekzio inbaditzaile eta ez-inbaditzaileak: txertaketaren eraginak M Ibar-Bariain, MCL Agara, A Rodríguez-Gascón, A Isla EKAIA EHUko Zientzia eta Teknologia aldizkaria, 2024 | | 2024 |
| Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study LC Tantalo, NAP Lieberman, C Pérez-Mañá, C Suñer, MV Mayans, ... The Lancet Microbe 4 (12), e994-e1004, 2023 | 15 | 2023 |
| Novel golden lipid nanoparticles with small interference ribonucleic acid for substrate reduction therapy in Fabry disease M Beraza-Millor, J Rodríguez-Castejón, J Miranda, A del Pozo-Rodríguez, ... Pharmaceutics 15 (7), 1936, 2023 | 3 | 2023 |
| Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study A Alarcia-Lacalle, H Barrasa, J Maynar, A Canut-Blasco, MÁ Solinís, ... Blood Purification 52 (5), 464-473, 2023 | 1 | 2023 |
| Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections? A Rodríguez-Gascón, A Alarcia-Lacalle, MÁ Solinís, ... Pharmaceutics 15 (4), 1185, 2023 | | 2023 |
| Golden lipid nanoparticles for gene therapy ADP Rodríguez, AR GASCÓN, IG AGUADO, MV PASCUAL, ... US Patent App. 17/783,022, 2023 | | 2023 |
| Absorción de fármacos MÁS Aspiazu, AR Gascón, AI Ruiz Fundamentos de farmacología básica y clínica, 181-198, 2023 | | 2023 |
| Terapia génica A del Pozo Rodríguez, AR Gascón, BC Hernáez Fundamentos de farmacología básica y clínica, 137-153, 2023 | 2 | 2023 |
| Extended infusion of piperacillin/tazobactam: pharmacokinetics in critically ill patients AA Lacalle, C Valdazo, AC Blasco, H Barrasa, AI Ruiz, AR Gascón XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 277-278, 2023 | | 2023 |
| ¿ Incrementa la descontaminación digestiva selectiva la resistencia a antibióticos? Comparación entre dos Servicios de Medicina Intensiva de un hospital terciario YL Vllar, AC Blasco, H Barrasa, AR Gascón XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 297-298, 2023 | | 2023 |
| SLNs como sistemas de transfección para el desarrollo deterapias CAR-T ex vivo MV Pascual, CS Cañadas, C Lawrie, AR Gascón, A del Pozo Rodríguez, ... XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 239-240, 2023 | | 2023 |
| Expression of a conserved sequence of SARS-CoV-2 for panβ-coronavirus vaccine development MA Galarreta, MB Millor, JR Castejón, A del Pozo Rodríguez, AR Gascón, ... XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 237-238, 2023 | | 2023 |
| Nanopartículas lipídicas funcionalizadas con GalNAc para suplementación génica: aplicación en la enfermedad de Fabry JR Castejón, MB Millor, MÁS Aspiazu, A del Pozo Rodríguez, AR Gascón XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 97-98, 2023 | | 2023 |
| siRNA vectors based on golden lipid nanoparticles for Fabry Disease MB Millor, JR Castejón, JM Gómez, A del Pozo Rodríguez, AR Gascón, ... XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 55-56, 2023 | | 2023 |
